TP53 and cancer: In p53-positive cancer cells, a combination of inhibitors of DNA replication initiation and genotoxic agents interfering the DNA chain elongation process may be an effective measure for cell death induction, whereas combination of Cdc7 inhibition with genotoxic agents targeting G2-M phase progression could be an effective measure in p53-negative cancer cells.